EFFECT OF TIRZEPATIDE VERSUS INSULIN DEGLUDEC ON LIVER FAT CONTENT AND ABDOMINAL ADIPOSE TISSUE IN PATIENTS WITH TYPE 2 DIABETES (SURPASS-3 MRI)

被引：0
|
作者：
Gastaldelli, A. [1 ]
Cusi, K. [2 ]
Lando, L. Fernandez [3 ]
Bray, R. [3 ]
Brouwers, B. [3 ]
Rodriguez, A. [3 ]
机构：
[1] CNR, Inst Clin Physiol, Cardiometab Risk Unit, Pisa, Italy
[2] Univ Florida, Div Endocrinol Diabet & Metab, Gainesville, FL USA
[3] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP030 / #8
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [41] Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes
    Cusi, K.
    Sanyal, A. J.
    Zhang, S.
    Hoogwerf, B. J.
    Chang, A. M.
    Jacober, S. J.
    Bue-Valleskey, J. M.
    Higdon, A. N.
    Bastyr, E. J., III
    Haupt, A.
    Hartman, M. L.
    DIABETES OBESITY & METABOLISM, 2016, 18 : 50 - 58
  • [42] MRI chemical shift imaging of the fat content of the pancreas and liver of patients with type 2 diabetes mellitus
    Chai, Jun
    Liu, Peng
    Jin, Erhu
    Su, Tianhao
    Zhang, Jie
    Shi, Kaining
    Hong, Xu
    Yin, Jie
    Yu, Hengchi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (02) : 476 - 480
  • [43] Tirzepatide vs basal insulins in people with type 2 diabetes and different baseline glycaemic patterns: post-hoc analyses of the SURPASS-3 and-4 trials
    Giorgino, F.
    Franco, D. R.
    Nicolay, C.
    Hemmingway, A.
    Rodriguez, A.
    Wiese, R. J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S315 - S315
  • [44] Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution
    Bozzetto, Lutgarda
    Prinster, Anna
    Mancini, Marcello
    Giacco, Rosalba
    De Natale, Claudia
    Salvatore, Marco
    Riccardi, Gabriele
    Rivellese, Angela A.
    Annuzzi, Giovanni
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (01) : 39 - 44
  • [45] Abdominal fat depots and their association with insulin resistance in patients with type 2 diabetes
    Garg, Umesh Kumar
    Mathur, Nitish
    Sahlot, Rahul
    Tiwari, Pradeep
    Sharma, Balram
    Saxena, Aditya
    Jainaw, Raj Kamal
    Agarwal, Laxman
    Gupta, Shalu
    Mathur, Sandeep Kumar
    PLOS ONE, 2023, 18 (12):
  • [46] Liver Fat Content and Hepatic Insulin Sensitivity in Overweight Patients With Type 1 Diabetes
    Llaurado, Gemma
    Sevastianova, Ksenia
    Sadevirta, Sanja
    Hakkarainen, Antti
    Lundbom, Nina
    Orho-Melander, Marju
    Groop, Per-Henrik
    Forsblom, Carol
    Yki-Jarvinen, Hannele
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : 607 - 616
  • [47] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
  • [48] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Liu, C.
    Tao, L. B.
    Wang, F.
    VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [49] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Xu, J.
    Lan, K.
    Wang, J.
    VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [50] Liver fat content, insulin absorption and action as determinants of insulin requirements in type 2 diabetes.
    Ryysy, L
    Häkkinen, AM
    Goto, T
    Vehkavaara, S
    Westerbacka, J
    Halavaara, J
    Yki-Järvinen, H
    DIABETOLOGIA, 1999, 42 : A83 - A83
12345